You are here

TGA Internet site archive

The content on this page and other TGA archive pages is provided to assist research and may contain references to activities or policies that have no current application. See the full archive disclaimer.

TGA presentations: 2019 BAA Conference, 31 October - 1 November 2019

20 November 2019

Disclaimer

These presentation papers are provided on the TGA's website solely for the purpose of indicating or suggesting what TGA representatives spoke about to the various conferences and seminars to which it relates. The papers are not legislative in nature and should not be taken to be statements of any law or policy in any way.

The Australian Government Department of Health (of which the TGA is a part) advises that (a) the presentation papers should not be relied upon in any way as representing a comprehensive description of regulatory requirements, and (b) cannot guarantee, and assumes no legal liability or responsibility for, the accuracy, currency or completeness of the information contained in the presentation paper.

Presentation: Risk based regulation of infectious diseases

  • Presented by: Dr Anuj Srivastava, A/g Director, Blood and Infectious Disease Safety Unit, Therapeutic Goods Administration
  • Presented at: 2019 BAA Conference
  • Presentation date: 1 November 2019
  • Presentation summary: TGA takes a risk-based approach to infectious disease safety for all therapeutic goods.

Presentation: TGA workshop

  • Presented by: Tony Manderson, Director, Biological Science Section, Scientific Evaluation Branch, Therapeutic Goods Administration
  • Presented at: 2019 BAA Conference
  • Presentation date: 1 November 2019
  • Presentation summary: An Overview of proposed changes to classification of tissue storage solutions, assessment of applications from tissue supplied from overseas (products on ARTG) and other TGA updates.